On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Ronald M. Bukowski

ResearcherPublications, citations & collaboration network

Ronald M. Bukowski is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Ronald M. Bukowski have?

ScholarIQindexed works

Ronald M. Bukowski has 614 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Ronald M. Bukowski have?

ScholarIQcitation count

Ronald M. Bukowski has 45,234 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Ronald M. Bukowski?

ScholarIQh-index

Ronald M. Bukowski has an h-index of 90 in OpenAlex.

What is the i10-index of Ronald M. Bukowski?

ScholarIQi10-index

Ronald M. Bukowski has an i10-index of 355 in OpenAlex.

What is the OpenAlex record for Ronald M. Bukowski?

ScholarIQopenalex

The OpenAlex for Ronald M. Bukowski is on the source record.

What are the most-cited papers on Ronald M. Bukowski?

ScholarIQmost cited works
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
Daniel Y.C. Heng, Wanling Xie, Meredith M. Regan, Mark Warren, Ali Golshayan, Chakshu Sahi, Bernhard J. Eigl, Joseph D. Ruether, Tina Cheng, Scott North, Peter Venner, Jennifer J. Knox, Kim N., Christian Kollmannsberger, David F. McDermott, William Oh, Michael B. Atkins, Ronald M. Bukowski, Brian I. Rini, Toni K. Choueiri
Journal of Clinical Oncology. 20092,140 CitationsOPEN ACCESS
Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial
Martin Gore, Cezary Szczylik, Camillo Porta, Sergio Bracarda, Georg A. Bjarnason, Stéphane Oudard, Subramanian Hariharan, Se‐Hoon Lee, John B.A.G. Haanen, Daniel Castellano, Eduard Vrdoljak, Patrick Schöffski, Paul N. Mainwaring, Alejandra Nieto, Jinyu Yuan, Ronald M. Bukowski
The Lancet Oncology. 2009591 Citations
Octreotide Acetate Long-Acting Formulation Versus Open-Label Subcutaneous Octreotide Acetate in Malignant Carcinoid Syndrome
Joseph Rubin, Jaffer A. Ajani, William J. Schirmer, Alan P. Venook, Ronald M. Bukowski, Rodney F. Pommier, Leonard B. Saltz, Paresh Dandona, Lowell Anthony
Journal of Clinical Oncology. 1999389 Citations

Related on ScholarIQ

470M+ articles · free account